Thurston Springer Miller Herd & Titak’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$9.22K	Buy	518 +1	+0.2%	+$18	﹤0.01%	1161
2025 Q1	$9.21K	Sell	517 -10	-2%	-$178	﹤0.01%	1148
2024 Q4	$15.7K	Buy	527 +2	+0.4%	+$60	﹤0.01%	780
2024 Q3	$8.2K	Buy	525 +16	+3%	+$250	﹤0.01%	1100
2024 Q2	$8.72K	Buy	+509	New	+$8.72K	﹤0.01%	1069